Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-05-29 @ 1:23 PM
Study NCT ID:
NCT05311566
Status:
RECRUITING
Last Update Posted:
2022-04-13
First Post:
2022-03-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer
Sponsor:
Lei Li
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Cervical Carcinoma | View |
| None | Chemoradiotherapy | View |
| None | Anti-programmed Cell Death Receptor 1 | View |
| None | Immunotherapy | View |
| None | Immune Checkpoint Inhibitor | View |
| None | Survival Outcomes | View |
| None | Adverse Events | View |
| None | Early Stage Cervical Cancer | View |
| None | Locally Advanced Cervical Cancer | View |
Keywords: